Page 11 - OHKF_Biotech_EN
P. 11

Figure 1    Summary of the Seven Recommendations


                  HK-SZ policies                                                      Central Government policies



                       Establishing anchor institutions in the region to expedite          Strengthening coordination and seeking
                  1    development of a biotech industrial cluster                    5    comprehensive authorisation
                       1.1:  Attracting leading enterprises to establish a presence in the Loop  5.1:  Establishing a designated body under the
                       1.2:  Providing ample funding for start-ups to nurture them into unicorns  Leading Group for the Development of the GBA
                       1.3:  Establishing a cross-border biotech mega research institute       to coordinate the collaborative development of
                                                                                               “one zone, two parks”
                                                                                           5.2:  Seeking comprehensive authorisation from the
                       Establishing all-stage ancillary facilities to optimise
                  2    biotech research and development supply chain                           Central Government to implement pilot policies
                                                                                               in biotech reform
                       2.1:  Establishing a Hong Kong Science and Development Of ce to
                          formulate a blueprint for biotech development
                       2.2:  Establishing ancillary facilities for preclinical research  6  Bridging the two cities’ systems and
                       2.3:  Expediting the approval of Phase 1 clinical trials in Hong Kong  regimes
                       2.4:  Coordinating multicentre clinical trials with “Hong Kong-style”   6.1:  Relaxing regulations set by the Negative List
                          management                                                           to allow designated enterprises to enter the
                       2.5:  Establishing production lines in the Loop and improving the product   Mainland market
                          launch regime for new drugs in the two cities                    6.2:  Coordinating the intellectual property regimes
                                                                                               in Hong Kong and the Mainland
                       Establishing a one-stop service platform in the Loop to             6.3:  Expediting evaluation and approval of new
                  3    provide professional support services                                   drugs in the Loop


                       Encouraging knowledge transfer in tertiary institutions and         Facilitating passage of bio-materials and
                  4    nurturing multi-skilled talent well-versed in biotech and       7   medical devices between Hong Kong
                       business                                                            and Shenzhen
                       4.1:  Establishing an assessment framework for knowledge transfer to foster a   7.1:  Optimising the mechanism by which Mainland
                          culture conducive to knowledge transfer on campus                    bio-materials are transported across
                       4.2:  Relaxing regulations on professors engaging in outside work to foster   the border into the Hong Kong park
                          knowledge transfer                                               7.2:  Easing restrictions on the import of
                       4.3:  Nurturing multi-skilled talent with backgrounds in biotech and business  bio-materials and medical devices


                                                                                                                                      9
   6   7   8   9   10   11   12   13   14   15   16